Researchers Study New Approach to Preventing, Treating Osteoporosis In Breast Cancer Survivors

Researchers at the University of Nebraska Medical Center College of

Nursing are involved in a study to evaluate a new approach in preventing

and treating osteoporosis in breast cancer survivors.

As a result of chemotherapy, at least 50 percent of women who are diagnosed

with breast cancer under age 50 experience premature ovarian failure that

leads to early menopause. Because estrogen influences growth of breast

cancer in women with estrogen receptor positive cancers, women with a history

of breast cancer are often not candidates for hormone replacement therapy,

the most effective preventive treatment for osteoporosis.

Osteoporosis causes deterioration of bone tissue, which leads to bone

fragility and an increased susceptibility to fractures of the hip, spine

and wrist, according to the National Osteoporosis Foundation. The disease

is a major public health threat for more than 28 million Americans, 80

percent of whom are women. An average of 24 percent of hip fracture patients

age 50 and over die in the year following their fracture. Caucasian and

Asian women are at increased risk for osteoporosis.

This is a  really significant problem. The good news is that more

women are surviving breast cancer than ever before, said Nancy Waltman,

Ph.D., associate professor of nursing, UNMC College of Nursing Lincoln

Division and principal investigator of the study. Unfortunately, they

have another concern — they may be at greater risk of osteoporosis than

healthy women, and the onset of osteoporosis may occur at an earlier age.

The purpose of the one-year study is to evaluate the feasibility and

effectiveness of a multi-component intervention in post-menopausal women

between the ages of 40 and 65 years, who have completed treatment for early

stage breast cancer and who cannot receive hormone replacement therapy

(HRT). Specific objectives of the pilot study are to determine adherence

of the intervention, and to look at differences between the groups such

as quality of life and vigor, and outcomes such as bone mineral density,

muscle strength and activity level.

Women in Omaha, Kearney and Scottsbluff will participate in the study.

The study is funded by the Regional West Foundation of Scottsbluff,

Neb., and national organizations: Oncology Nursing Foundation; Sigma Theta

Tau International Honor Society of Nursing; and the American Nurses Foundation.

The study will evaluate a group of 30 women who will taking calcium

with vitamin D, and Fosamax®, a drug shown to rebuild bone mass. Women

also participate in strength and weight training exercises and receive

education on osteoporosis as well as strategies to promote adherence to

the intervention. A control group of seven to 12 women will follow the

same protocol but without strength and weight training.

Eligible study participants will receive evaluations, including muscle

strength and balance tests and bone mineral density screenings using Dual-Energy

X-ray Absorptiometry (DEXA). DEXA screening is painless, takes less than

15 minutes and doesnt require clothes removal. Women will be evaluated

at various intervals during the study.

Researchers say the study is unique because it combines exercise with

other components used in the fight against osteoporosis — calcium, vitamin

D and drugs that build bone mass.

We want to know how much exercise improves on the effects of the medication,

said Janice Twiss, Ph.D., UNMC associate professor of nursing and womens

health nurse practitioner and co-principal investigator of the study. Dr.

Twiss said a strength-weight training program will be used to strengthen

muscle and bone mass in the hip, spine and wrist.

After age 65, women who arent on HRT are at great risk for osteoporotic

fractures, said Twiss said. Women whove had breast cancer and have gone

through chemotherapy have a longer period of time where bone is lost.

She said there is a growing concern in regards to osteoporosis as people

live longer. The estimated annual cost of osteoporosis is $15 to 20 million

annually.

Its a more expensive chronic illness than congestive heart failure

and asthma, Dr. Twiss said. Women can live a long time, but theyre disabled.

They end up in a nursing home.

She said women get fractures in their spine simply by reaching up to

get something, sneezing or walking down steps. Most often, hip fractures

usually occur with a fall.

An important part of the study evaluates study participants adherence

with components of the study. Weve recognized that adherence not only

to exercise, but to medications, is a problem. So weve included strategies

to improve adherence, Dr. Waltman said.

Information gathered from this study will be used for a larger study.

In June, Drs. Waltman and Twiss published baseline results of bone mineral

density in postmenopausal breast cancer survivors in the Journal of the

American Academy of Nurse Practitioners. They were surprised to find 80

percent of the women had signs of osteopenia or osteoporosis and about

45 percent were not aware they had a problem because theyd never been

told.

Very few women had bone mineral density measurements before the study,

Dr. Waltman said. Many of these women didnt even realize that osteoporosis

was something they should be concerned about it. The findings suggest the

need for health care providers to educate breast cancer survivors or women

not on hormone replacement therapy that they are at risk for osteoporosis

and they should be screened.

Other researchers participating in the study are: Carol Ott, Ph.D.,

UNMC College of Nursing Kearney Division; Gloria Gross, Ph.D., UNMC College

of Nursing West Nebraska Division; Ada Lindsey, Ph.D., UNMC College of

Nursing, Omaha; and Timothy Moore, M.D., UNMC College of Medicine, Omaha.